Metraipolis › archive › dc_2ea471b40fc1

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report — Europe PMC PMID:41497777

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41497777
DOI
10.1002/ccr3.71766
License (as archived)
solo-consultazione
Archived
2026-11-07T02:11:49.173Z
SHA-256 of the archived text
c4159686b369928e1c9b6dc2d7281f926beb7f550b1400eef27e5eda0353c972
Stable URL of this page
https://metraipolis.com/documento/dc_2ea471b40fc1

How to cite

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report — Europe PMC PMID:41497777 — Europe PMC (en), https://europepmc.org/article/MED/41497777 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ea471b40fc1 (Metraipolis archive dc_2ea471b40fc1, sha256 c4159686b369928e1c9b6dc2d7281f926beb7f550b1400eef27e5eda0353c972)
BibTeX
@misc{dc2ea471b40fc1,
  title = {Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report — Europe PMC PMID:41497777},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41497777},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ea471b40fc1; sha256 c4159686b369928e1c9b6dc2d7281f926beb7f550b1400eef27e5eda0353c972},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41497777. Agents can read the archived copy with the MCP tool read_document.